Further, a 444A > C SNP polymorphism in the LTC4S gene (encodes for leukotriene C4 synthase enzyme) can potentiate asthma risk along with reduced sensitivity toward CysLT1R antagonist, Zafirlukast. This evidence concerns the gene LTC4S and asthma.